A graphic snippet from the FT is encouragement that global cases and deaths are on the downslope (still higher but at a slowing pace).
While the numbers on the vertical scale are not corrected for population a look at how the slope for each country is performing is a better guide – acting early paid dividends. In absolute terms you can see the human death toll inflicted on the US from the three months spent in denial and delay.
Antiviral medicine remdesivir is being used to treat cov1 COVID-19 patients at a Chicago hospital,
A small study only, and note: The lack of a control arm in the study could make interpreting the results more challenging, so not leaping to conclusions:
The University of Chicago Medicine recruited 125 people with Covid-19
two Phase 3 clinical trials
113 had severe disease
All the patients been treated with daily infusions of remdesivir
“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
The US stock indices closed higher on the day led by the Nasdaq index. The S&P and Dow closed higher as well but the gains were well behind the tech heavy Nasdaq. For the Dow, the blame fall firmly on Boeing which alone fell over 7% on the day.
The final numbers are showing:
S&P index rose 16.19 points or 0.58% at 2799.55
Nasdaq index rose 139.18 points or 1.66% at 8532.36